Person

Sang Yi

Group President, Asia Pacific, Zimmer Biomet

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$5.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 29, 2026ZBHSale4,200$82.64$347K
May 29, 2026ZBHSale800$82.66$66K
Feb 12, 2026ZBHSale1,000$96.49$96K
Sep 11, 2025ZBHSale1,200$103.59$124K
Jun 13, 2025ZBHSale800$92.51$74K
Jun 11, 2025ZBHSale1,000$95.00$95K
May 31, 2024ZBHSale12,857$114.69$1.5M
Mar 7, 2024ZBHSale1,705$126.86$216K
Dec 14, 2021ZBHSale2,600$124.14$323K
Dec 14, 2021ZBHSale200$124.18$25K
Nov 18, 2020ZBHSale1,200$152.59$183K
May 29, 2020ZBHSale3,000$125.38$376K
Aug 8, 2019ZBHSale147$138.70$20K
May 24, 2019ZBHSale426$114.88$49K
Jun 12, 2017ZBHSale4,300$123.62$532K
Jun 9, 2017ZBHSale474$124.93$59K
Jun 9, 2017ZBHSale3,550$124.86$443K
Jun 9, 2017ZBHSale6,097$124.86$761K
Jun 9, 2017ZBHSale3,310$124.86$413K

SEC reporting-owner ID (CIK) 1635943 · all filings on EDGAR